

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | cytidine deamination (GO:0009972) | 8.38494325 |
| 2 | cytidine metabolic process (GO:0046087) | 8.38494325 |
| 3 | cytidine catabolic process (GO:0006216) | 8.38494325 |
| 4 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 7.62555678 |
| 5 | DNA deamination (GO:0045006) | 7.33184234 |
| 6 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 6.91656447 |
| 7 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 5.83254824 |
| 8 | actin nucleation (GO:0045010) | 5.00313234 |
| 9 | negative regulation by host of viral transcription (GO:0043922) | 4.92806444 |
| 10 | positive regulation of interleukin-8 secretion (GO:2000484) | 4.83105891 |
| 11 | regulation of activation of Janus kinase activity (GO:0010533) | 4.79464345 |
| 12 | positive regulation of B cell differentiation (GO:0045579) | 4.22563585 |
| 13 | DNA demethylation (GO:0080111) | 4.00553128 |
| 14 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.97535990 |
| 15 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.92864119 |
| 16 | pyrimidine nucleoside catabolic process (GO:0046135) | 3.91651347 |
| 17 | negative T cell selection (GO:0043383) | 3.78866990 |
| 18 | sequestering of actin monomers (GO:0042989) | 3.76327227 |
| 19 | eosinophil chemotaxis (GO:0048245) | 3.72268333 |
| 20 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.71504802 |
| 21 | DNA dealkylation (GO:0035510) | 3.70456504 |
| 22 | regulation of T cell tolerance induction (GO:0002664) | 3.67865681 |
| 23 | regulation of interleukin-8 secretion (GO:2000482) | 3.66295780 |
| 24 | positive thymic T cell selection (GO:0045059) | 3.65060872 |
| 25 | T cell migration (GO:0072678) | 3.57419041 |
| 26 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 3.56897354 |
| 27 | positive regulation of calcium-mediated signaling (GO:0050850) | 3.51656061 |
| 28 | ATP synthesis coupled proton transport (GO:0015986) | 3.44124353 |
| 29 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.44124353 |
| 30 | eosinophil migration (GO:0072677) | 3.39798848 |
| 31 | positive T cell selection (GO:0043368) | 3.38950404 |
| 32 | base-excision repair, AP site formation (GO:0006285) | 3.36297540 |
| 33 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.35595118 |
| 34 | positive regulation of lymphocyte migration (GO:2000403) | 3.35409235 |
| 35 | protein polyglutamylation (GO:0018095) | 3.34005410 |
| 36 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.33734781 |
| 37 | negative regulation of B cell proliferation (GO:0030889) | 3.32512631 |
| 38 | regulation of B cell differentiation (GO:0045577) | 3.26538273 |
| 39 | pyrimidine nucleotide catabolic process (GO:0006244) | 3.26031854 |
| 40 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.23505112 |
| 41 | macrophage chemotaxis (GO:0048246) | 3.23036452 |
| 42 | negative regulation of T cell apoptotic process (GO:0070233) | 3.21972886 |
| 43 | pyrimidine-containing compound catabolic process (GO:0072529) | 3.21833357 |
| 44 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.21159564 |
| 45 | respiratory electron transport chain (GO:0022904) | 3.17729488 |
| 46 | regulation of chronic inflammatory response (GO:0002676) | 3.17398694 |
| 47 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.16268176 |
| 48 | positive regulation of T cell apoptotic process (GO:0070234) | 3.15156311 |
| 49 | regulation of tolerance induction (GO:0002643) | 3.15087057 |
| 50 | estrogen biosynthetic process (GO:0006703) | 3.14848509 |
| 51 | T cell costimulation (GO:0031295) | 3.13852112 |
| 52 | cytolysis (GO:0019835) | 3.13040179 |
| 53 | positive regulation of tolerance induction (GO:0002645) | 3.12558805 |
| 54 | negative regulation of sodium ion transport (GO:0010766) | 3.11814576 |
| 55 | negative thymic T cell selection (GO:0045060) | 3.11130713 |
| 56 | cellular response to interleukin-15 (GO:0071350) | 3.10638841 |
| 57 | negative regulation of viral genome replication (GO:0045071) | 3.10282531 |
| 58 | electron transport chain (GO:0022900) | 3.09997180 |
| 59 | lymphocyte costimulation (GO:0031294) | 3.09934244 |
| 60 | regulation of lymphocyte chemotaxis (GO:1901623) | 3.08010410 |
| 61 | proteasome assembly (GO:0043248) | 3.07343161 |
| 62 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.03989714 |
| 63 | protein complex biogenesis (GO:0070271) | 3.03700635 |
| 64 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.01617325 |
| 65 | lymphocyte chemotaxis (GO:0048247) | 3.00563299 |
| 66 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.00037878 |
| 67 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.97328406 |
| 68 | T cell receptor signaling pathway (GO:0050852) | 2.96468520 |
| 69 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.95024400 |
| 70 | deoxyribose phosphate catabolic process (GO:0046386) | 2.93657144 |
| 71 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.93447204 |
| 72 | modulation by host of viral transcription (GO:0043921) | 2.86303486 |
| 73 | modulation by host of symbiont transcription (GO:0052472) | 2.86303486 |
| 74 | deoxyribonucleotide catabolic process (GO:0009264) | 2.85405955 |
| 75 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 2.85370391 |
| 76 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.83414358 |
| 77 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.83414358 |
| 78 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.81935369 |
| 79 | regulation of regulatory T cell differentiation (GO:0045589) | 2.81906299 |
| 80 | platelet dense granule organization (GO:0060155) | 2.81762445 |
| 81 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.80060472 |
| 82 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.80060472 |
| 83 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.80060472 |
| 84 | autophagic vacuole fusion (GO:0000046) | 2.79810087 |
| 85 | thymic T cell selection (GO:0045061) | 2.78098213 |
| 86 | positive regulation of defense response to virus by host (GO:0002230) | 2.77398034 |
| 87 | modulation of transcription in other organism involved in symbiotic interaction (GO:0052312) | 2.76906750 |
| 88 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.76567372 |
| 89 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.75299781 |
| 90 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.73680181 |
| 91 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 2.73385448 |
| 92 | positive regulation of T cell migration (GO:2000406) | 2.72959814 |
| 93 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 2.72504082 |
| 94 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.72073248 |
| 95 | mast cell activation (GO:0045576) | 2.71608459 |
| 96 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.70611663 |
| 97 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.66905293 |
| 98 | protein neddylation (GO:0045116) | 2.65584034 |
| 99 | * GPI anchor biosynthetic process (GO:0006506) | 2.65391214 |
| 100 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.63726002 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 9.01620699 |
| 2 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 5.47671405 |
| 3 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 4.66580586 |
| 4 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.99247157 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.29584287 |
| 6 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.19536942 |
| 7 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 3.05617464 |
| 8 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.94043477 |
| 9 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.89555875 |
| 10 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.69770731 |
| 11 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.57031811 |
| 12 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.43768420 |
| 13 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.38036017 |
| 14 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.37049895 |
| 15 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.32453719 |
| 16 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.29090794 |
| 17 | MYB_26560356_Chip-Seq_TH2_Human | 2.18254591 |
| 18 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.16003682 |
| 19 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.09926663 |
| 20 | * HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.05796139 |
| 21 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.92055046 |
| 22 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.90078515 |
| 23 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.89683783 |
| 24 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.89116167 |
| 25 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.88641883 |
| 26 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.87335291 |
| 27 | VDR_22108803_ChIP-Seq_LS180_Human | 1.79382877 |
| 28 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.71818850 |
| 29 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.65191162 |
| 30 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.61934143 |
| 31 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.53202332 |
| 32 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.52947583 |
| 33 | * SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.46656630 |
| 34 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.45999729 |
| 35 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.44224716 |
| 36 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.43450226 |
| 37 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.41241195 |
| 38 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.39405863 |
| 39 | MYB_26560356_Chip-Seq_TH1_Human | 1.35787016 |
| 40 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.34998336 |
| 41 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.32735263 |
| 42 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.30304422 |
| 43 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.29595464 |
| 44 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.26638767 |
| 45 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.24108379 |
| 46 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.23316739 |
| 47 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.20584962 |
| 48 | UTX_26944678_Chip-Seq_JUKART_Human | 1.19687305 |
| 49 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.18947906 |
| 50 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.18347554 |
| 51 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.14540391 |
| 52 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.13246995 |
| 53 | AR_20517297_ChIP-Seq_VCAP_Human | 1.10165575 |
| 54 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.09824214 |
| 55 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.09715654 |
| 56 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.09188340 |
| 57 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.07021778 |
| 58 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.05676568 |
| 59 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.05049289 |
| 60 | P300_27268052_Chip-Seq_Bcells_Human | 1.03414369 |
| 61 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.01744467 |
| 62 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.99653627 |
| 63 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.99497163 |
| 64 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.98244342 |
| 65 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.97038447 |
| 66 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.96896303 |
| 67 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.96665580 |
| 68 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.95941994 |
| 69 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.95450962 |
| 70 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 0.95401182 |
| 71 | MAF_26560356_Chip-Seq_TH2_Human | 0.94965798 |
| 72 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.92307316 |
| 73 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.92256980 |
| 74 | EZH2_22144423_ChIP-Seq_EOC_Human | 0.91590717 |
| 75 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.90870377 |
| 76 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.90821376 |
| 77 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.90217378 |
| 78 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.89727687 |
| 79 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.88757672 |
| 80 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.88757672 |
| 81 | NCOR_22424771_ChIP-Seq_293T_Human | 0.88378981 |
| 82 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.88204765 |
| 83 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.87703346 |
| 84 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 0.86153484 |
| 85 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.85625137 |
| 86 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.84961964 |
| 87 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.84458542 |
| 88 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.82831614 |
| 89 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.82722493 |
| 90 | GATA1_22025678_ChIP-Seq_K562_Human | 0.81469970 |
| 91 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 0.80558079 |
| 92 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 0.80050044 |
| 93 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.79886167 |
| 94 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.79562485 |
| 95 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.78951661 |
| 96 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.78748570 |
| 97 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.78582424 |
| 98 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 0.78441892 |
| 99 | GATA3_26560356_Chip-Seq_TH1_Human | 0.77749692 |
| 100 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.75969756 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005671_abnormal_response_to | 4.79127048 |
| 2 | MP0001835_abnormal_antigen_presentation | 3.39298252 |
| 3 | MP0003763_abnormal_thymus_physiology | 3.28053959 |
| 4 | MP0009785_altered_susceptibility_to | 2.91338987 |
| 5 | MP0009333_abnormal_splenocyte_physiolog | 2.81192112 |
| 6 | MP0005000_abnormal_immune_tolerance | 2.44506281 |
| 7 | MP0004147_increased_porphyrin_level | 2.36034210 |
| 8 | MP0003806_abnormal_nucleotide_metabolis | 2.34285245 |
| 9 | MP0002148_abnormal_hypersensitivity_rea | 2.32698150 |
| 10 | MP0000465_gastrointestinal_hemorrhage | 2.31684139 |
| 11 | MP0005075_abnormal_melanosome_morpholog | 2.24816006 |
| 12 | MP0001800_abnormal_humoral_immune | 2.18929862 |
| 13 | MP0005025_abnormal_response_to | 2.18624776 |
| 14 | MP0005464_abnormal_platelet_physiology | 2.11540185 |
| 15 | MP0002723_abnormal_immune_serum | 2.06559679 |
| 16 | MP0002420_abnormal_adaptive_immunity | 2.00983020 |
| 17 | MP0001819_abnormal_immune_cell | 2.00191382 |
| 18 | MP0005451_abnormal_body_composition | 1.99321828 |
| 19 | MP0006082_CNS_inflammation | 1.96009780 |
| 20 | MP0002166_altered_tumor_susceptibility | 1.85645989 |
| 21 | MP0002452_abnormal_antigen_presenting | 1.81520053 |
| 22 | MP0002837_dystrophic_cardiac_calcinosis | 1.79434168 |
| 23 | MP0006072_abnormal_retinal_apoptosis | 1.77745577 |
| 24 | MP0001919_abnormal_reproductive_system | 1.76187326 |
| 25 | MP0002398_abnormal_bone_marrow | 1.75717835 |
| 26 | MP0009379_abnormal_foot_pigmentation | 1.73095719 |
| 27 | MP0002163_abnormal_gland_morphology | 1.68725676 |
| 28 | MP0002876_abnormal_thyroid_physiology | 1.66787613 |
| 29 | MP0008875_abnormal_xenobiotic_pharmacok | 1.61956589 |
| 30 | MP0000716_abnormal_immune_system | 1.61486036 |
| 31 | MP0005389_reproductive_system_phenotype | 1.60990772 |
| 32 | MP0001905_abnormal_dopamine_level | 1.59335767 |
| 33 | MP0005645_abnormal_hypothalamus_physiol | 1.56785038 |
| 34 | MP0001790_abnormal_immune_system | 1.55063985 |
| 35 | MP0005387_immune_system_phenotype | 1.55063985 |
| 36 | MP0000372_irregular_coat_pigmentation | 1.54610227 |
| 37 | MP0000015_abnormal_ear_pigmentation | 1.54062844 |
| 38 | MP0005084_abnormal_gallbladder_morpholo | 1.48939402 |
| 39 | MP0002102_abnormal_ear_morphology | 1.46554014 |
| 40 | MP0002095_abnormal_skin_pigmentation | 1.44448821 |
| 41 | MP0002006_tumorigenesis | 1.41461923 |
| 42 | MP0006036_abnormal_mitochondrial_physio | 1.40809315 |
| 43 | MP0002822_catalepsy | 1.39718890 |
| 44 | MP0010155_abnormal_intestine_physiology | 1.39082805 |
| 45 | MP0005646_abnormal_pituitary_gland | 1.38578314 |
| 46 | MP0003866_abnormal_defecation | 1.36409819 |
| 47 | MP0005174_abnormal_tail_pigmentation | 1.34050718 |
| 48 | MP0002405_respiratory_system_inflammati | 1.32565521 |
| 49 | MP0000689_abnormal_spleen_morphology | 1.30340718 |
| 50 | MP0003436_decreased_susceptibility_to | 1.30147538 |
| 51 | MP0003075_altered_response_to | 1.29902262 |
| 52 | MP0002429_abnormal_blood_cell | 1.29070959 |
| 53 | MP0001845_abnormal_inflammatory_respons | 1.26624496 |
| 54 | MP0004145_abnormal_muscle_electrophysio | 1.26105044 |
| 55 | MP0002419_abnormal_innate_immunity | 1.24898601 |
| 56 | MP0002722_abnormal_immune_system | 1.22818301 |
| 57 | MP0008469_abnormal_protein_level | 1.19724828 |
| 58 | MP0000703_abnormal_thymus_morphology | 1.19373121 |
| 59 | MP0008789_abnormal_olfactory_epithelium | 1.18694806 |
| 60 | MP0000569_abnormal_digit_pigmentation | 1.18202238 |
| 61 | MP0009764_decreased_sensitivity_to | 1.18043659 |
| 62 | MP0008872_abnormal_physiological_respon | 1.16844959 |
| 63 | MP0005636_abnormal_mineral_homeostasis | 1.14752739 |
| 64 | MP0002160_abnormal_reproductive_system | 1.09480426 |
| 65 | MP0003186_abnormal_redox_activity | 1.06888007 |
| 66 | MP0005253_abnormal_eye_physiology | 1.06049028 |
| 67 | MP0009697_abnormal_copulation | 1.05386372 |
| 68 | MP0001968_abnormal_touch/_nociception | 1.03345367 |
| 69 | MP0001853_heart_inflammation | 1.02880414 |
| 70 | MP0009763_increased_sensitivity_to | 1.00900093 |
| 71 | MP0005551_abnormal_eye_electrophysiolog | 0.99605079 |
| 72 | MP0005166_decreased_susceptibility_to | 0.98113209 |
| 73 | MP0002132_abnormal_respiratory_system | 0.97379288 |
| 74 | MP0003786_premature_aging | 0.94280978 |
| 75 | MP0005085_abnormal_gallbladder_physiolo | 0.93848373 |
| 76 | MP0005410_abnormal_fertilization | 0.93184993 |
| 77 | MP0009643_abnormal_urine_homeostasis | 0.92071970 |
| 78 | MP0003448_altered_tumor_morphology | 0.91505853 |
| 79 | MP0000685_abnormal_immune_system | 0.91033861 |
| 80 | MP0001765_abnormal_ion_homeostasis | 0.90707937 |
| 81 | MP0008995_early_reproductive_senescence | 0.90033286 |
| 82 | MP0003195_calcinosis | 0.89420274 |
| 83 | MP0000681_abnormal_thyroid_gland | 0.88134668 |
| 84 | MP0001501_abnormal_sleep_pattern | 0.84100739 |
| 85 | MP0002019_abnormal_tumor_incidence | 0.83782447 |
| 86 | MP0001873_stomach_inflammation | 0.83684350 |
| 87 | MP0003045_fibrosis | 0.81135942 |
| 88 | MP0005379_endocrine/exocrine_gland_phen | 0.81120492 |
| 89 | MP0010386_abnormal_urinary_bladder | 0.79529610 |
| 90 | MP0009765_abnormal_xenobiotic_induced | 0.78207696 |
| 91 | MP0008058_abnormal_DNA_repair | 0.76621389 |
| 92 | MP0003011_delayed_dark_adaptation | 0.76482408 |
| 93 | MP0003787_abnormal_imprinting | 0.74924071 |
| 94 | MP0001664_abnormal_digestion | 0.71827750 |
| 95 | MP0001542_abnormal_bone_strength | 0.71411709 |
| 96 | MP0002277_abnormal_respiratory_mucosa | 0.71220409 |
| 97 | MP0005360_urolithiasis | 0.71026227 |
| 98 | MP0003656_abnormal_erythrocyte_physiolo | 0.69866797 |
| 99 | MP0002933_joint_inflammation | 0.69123558 |
| 100 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.68880469 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | T lymphocytopenia (HP:0005403) | 4.60692197 |
| 2 | Aplastic anemia (HP:0001915) | 4.47538598 |
| 3 | Abnormality of T cell number (HP:0011839) | 4.40263276 |
| 4 | Severe combined immunodeficiency (HP:0004430) | 3.93620206 |
| 5 | Increased intramyocellular lipid droplets (HP:0012240) | 3.79386028 |
| 6 | Reduced antithrombin III activity (HP:0001976) | 3.71346426 |
| 7 | Hepatocellular necrosis (HP:0001404) | 3.56339451 |
| 8 | Abnormality of the prostate (HP:0008775) | 3.56101704 |
| 9 | Mitochondrial inheritance (HP:0001427) | 3.54269796 |
| 10 | Chronic obstructive pulmonary disease (HP:0006510) | 3.46274124 |
| 11 | Obstructive lung disease (HP:0006536) | 3.46274124 |
| 12 | Autoimmune hemolytic anemia (HP:0001890) | 3.38678508 |
| 13 | Hypoproteinemia (HP:0003075) | 3.37621721 |
| 14 | IgG deficiency (HP:0004315) | 3.24490204 |
| 15 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.24287450 |
| 16 | Hepatic necrosis (HP:0002605) | 3.22012559 |
| 17 | Increased muscle lipid content (HP:0009058) | 3.21110250 |
| 18 | Acute necrotizing encephalopathy (HP:0006965) | 3.20895824 |
| 19 | Abnormality of T cells (HP:0002843) | 3.17703921 |
| 20 | 3-Methylglutaconic aciduria (HP:0003535) | 3.12317351 |
| 21 | Increased IgM level (HP:0003496) | 3.03519729 |
| 22 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.02490156 |
| 23 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.02490156 |
| 24 | Cerebral palsy (HP:0100021) | 2.97975264 |
| 25 | Combined immunodeficiency (HP:0005387) | 2.96575853 |
| 26 | Increased CSF lactate (HP:0002490) | 2.91344491 |
| 27 | Increased hepatocellular lipid droplets (HP:0006565) | 2.89527715 |
| 28 | Thyroiditis (HP:0100646) | 2.87944857 |
| 29 | Abnormality of eosinophils (HP:0001879) | 2.79338245 |
| 30 | Chronic diarrhea (HP:0002028) | 2.71447812 |
| 31 | Lipid accumulation in hepatocytes (HP:0006561) | 2.63510550 |
| 32 | Progressive macrocephaly (HP:0004481) | 2.59314964 |
| 33 | Acute encephalopathy (HP:0006846) | 2.56825162 |
| 34 | Meningitis (HP:0001287) | 2.54923576 |
| 35 | Oral leukoplakia (HP:0002745) | 2.52040582 |
| 36 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.49726376 |
| 37 | Renal Fanconi syndrome (HP:0001994) | 2.47559856 |
| 38 | Ureteral stenosis (HP:0000071) | 2.45197202 |
| 39 | Chest pain (HP:0100749) | 2.43366421 |
| 40 | Pulmonary fibrosis (HP:0002206) | 2.41142269 |
| 41 | Severe visual impairment (HP:0001141) | 2.38491716 |
| 42 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.38063012 |
| 43 | Exertional dyspnea (HP:0002875) | 2.36558978 |
| 44 | Granulocytopenia (HP:0001913) | 2.34428713 |
| 45 | Panhypogammaglobulinemia (HP:0003139) | 2.31904555 |
| 46 | Eosinophilia (HP:0001880) | 2.31545830 |
| 47 | Ureteral obstruction (HP:0006000) | 2.29477246 |
| 48 | Metaphyseal dysplasia (HP:0100255) | 2.28606410 |
| 49 | Gastrointestinal infarctions (HP:0005244) | 2.26866792 |
| 50 | Gangrene (HP:0100758) | 2.24177963 |
| 51 | Abnormality of B cell number (HP:0010975) | 2.20824032 |
| 52 | Hypothermia (HP:0002045) | 2.19966655 |
| 53 | B lymphocytopenia (HP:0010976) | 2.19708656 |
| 54 | Skin rash (HP:0000988) | 2.18836683 |
| 55 | Encephalitis (HP:0002383) | 2.17787717 |
| 56 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.17328522 |
| 57 | Joint swelling (HP:0001386) | 2.16779742 |
| 58 | Abnormal number of erythroid precursors (HP:0012131) | 2.15534664 |
| 59 | Pulmonary infiltrates (HP:0002113) | 2.14828332 |
| 60 | Leukocytosis (HP:0001974) | 2.14253044 |
| 61 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.12505840 |
| 62 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.12505840 |
| 63 | Abnormal protein glycosylation (HP:0012346) | 2.12505840 |
| 64 | Abnormal glycosylation (HP:0012345) | 2.12505840 |
| 65 | Agammaglobulinemia (HP:0004432) | 2.11891894 |
| 66 | Recurrent fungal infections (HP:0002841) | 2.10726035 |
| 67 | Abnormality of the pleura (HP:0002103) | 2.09019697 |
| 68 | Abolished electroretinogram (ERG) (HP:0000550) | 2.08419657 |
| 69 | Hemoptysis (HP:0002105) | 2.08398538 |
| 70 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.06674046 |
| 71 | Recurrent cutaneous fungal infections (HP:0011370) | 2.06674046 |
| 72 | Cerebral edema (HP:0002181) | 2.06320026 |
| 73 | Lactic acidosis (HP:0003128) | 2.05537118 |
| 74 | Vasculitis (HP:0002633) | 2.05210017 |
| 75 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.04887375 |
| 76 | Medial flaring of the eyebrow (HP:0010747) | 2.03557449 |
| 77 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.03534651 |
| 78 | Abnormality of macular pigmentation (HP:0008002) | 2.03427525 |
| 79 | Abnormality of midbrain morphology (HP:0002418) | 2.03259070 |
| 80 | Molar tooth sign on MRI (HP:0002419) | 2.03259070 |
| 81 | Microretrognathia (HP:0000308) | 2.02880824 |
| 82 | Optic disc pallor (HP:0000543) | 2.02679324 |
| 83 | Increased serum lactate (HP:0002151) | 2.02523498 |
| 84 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.02211139 |
| 85 | Epistaxis (HP:0000421) | 1.98820197 |
| 86 | Sensory axonal neuropathy (HP:0003390) | 1.95696762 |
| 87 | Abnormality of male internal genitalia (HP:0000022) | 1.93270508 |
| 88 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 1.92363957 |
| 89 | Hypoplasia of the thymus (HP:0000778) | 1.91549671 |
| 90 | Dicarboxylic aciduria (HP:0003215) | 1.91227102 |
| 91 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.91227102 |
| 92 | Amaurosis fugax (HP:0100576) | 1.91065031 |
| 93 | Renal cortical cysts (HP:0000803) | 1.90324670 |
| 94 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.88028973 |
| 95 | Congenital stationary night blindness (HP:0007642) | 1.87097198 |
| 96 | Premature graying of hair (HP:0002216) | 1.86183469 |
| 97 | Recurrent skin infections (HP:0001581) | 1.83363154 |
| 98 | Abnormality of T cell physiology (HP:0011840) | 1.82101624 |
| 99 | Abnormality of the columella (HP:0009929) | 1.81685889 |
| 100 | Gingival bleeding (HP:0000225) | 1.79015177 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TXK | 5.21379283 |
| 2 | TESK2 | 4.76324058 |
| 3 | KDR | 4.49215358 |
| 4 | MAP3K12 | 3.70813636 |
| 5 | VRK2 | 3.67114920 |
| 6 | TLK1 | 2.61985346 |
| 7 | ZAK | 2.29080683 |
| 8 | MAP4K1 | 2.26570789 |
| 9 | DAPK2 | 2.22725684 |
| 10 | BCKDK | 2.14334771 |
| 11 | VRK1 | 2.05946219 |
| 12 | SCYL2 | 2.01427913 |
| 13 | DAPK1 | 2.00919784 |
| 14 | TAOK3 | 1.97578829 |
| 15 | TESK1 | 1.91387108 |
| 16 | PIM2 | 1.90720611 |
| 17 | ITK | 1.83006038 |
| 18 | NUAK1 | 1.77024266 |
| 19 | STK16 | 1.65374757 |
| 20 | MAP3K11 | 1.58859540 |
| 21 | ADRBK2 | 1.47381572 |
| 22 | SYK | 1.39459790 |
| 23 | GRK6 | 1.38922603 |
| 24 | MYLK | 1.34519325 |
| 25 | BMPR2 | 1.31019304 |
| 26 | FES | 1.29431870 |
| 27 | MST4 | 1.26177152 |
| 28 | DAPK3 | 1.21953790 |
| 29 | LIMK1 | 1.20097634 |
| 30 | PRKCQ | 1.18510875 |
| 31 | KIT | 1.14195864 |
| 32 | ZAP70 | 1.14163931 |
| 33 | TNK2 | 1.11309735 |
| 34 | MAP4K2 | 1.10191414 |
| 35 | GRK7 | 1.08019458 |
| 36 | RIPK4 | 1.06432162 |
| 37 | RPS6KA4 | 1.04242487 |
| 38 | BMPR1B | 1.03303655 |
| 39 | IKBKB | 0.97787409 |
| 40 | LCK | 0.93683880 |
| 41 | TEC | 0.92169057 |
| 42 | BUB1 | 0.88322598 |
| 43 | PIM1 | 0.85852097 |
| 44 | RPS6KA5 | 0.85042633 |
| 45 | CCNB1 | 0.84990920 |
| 46 | TAF1 | 0.82596120 |
| 47 | CAMKK2 | 0.79733858 |
| 48 | ILK | 0.78838297 |
| 49 | CDK19 | 0.77231756 |
| 50 | LYN | 0.75175984 |
| 51 | MAP2K7 | 0.72205902 |
| 52 | MAP3K5 | 0.68003906 |
| 53 | CSF1R | 0.67961086 |
| 54 | CSNK1G3 | 0.67910111 |
| 55 | CSK | 0.67642784 |
| 56 | TIE1 | 0.63942254 |
| 57 | IKBKE | 0.62542613 |
| 58 | AURKA | 0.61573112 |
| 59 | ABL2 | 0.58557987 |
| 60 | GRK1 | 0.58131314 |
| 61 | MAPKAPK3 | 0.55735827 |
| 62 | GRK5 | 0.55209912 |
| 63 | ERBB3 | 0.54091259 |
| 64 | BTK | 0.53519160 |
| 65 | CSNK1G1 | 0.52728810 |
| 66 | ERN1 | 0.51528561 |
| 67 | MUSK | 0.48340602 |
| 68 | INSRR | 0.48208079 |
| 69 | JAK3 | 0.48185148 |
| 70 | OBSCN | 0.45669119 |
| 71 | ROCK1 | 0.45603872 |
| 72 | ARAF | 0.42917726 |
| 73 | PIK3CG | 0.41740791 |
| 74 | FRK | 0.40988205 |
| 75 | MAP2K6 | 0.40122822 |
| 76 | CSNK1G2 | 0.39417528 |
| 77 | DYRK2 | 0.38493433 |
| 78 | WNK4 | 0.38481019 |
| 79 | FYN | 0.37058329 |
| 80 | BLK | 0.36382539 |
| 81 | PIK3CA | 0.35913938 |
| 82 | ATR | 0.34295006 |
| 83 | PRKACA | 0.33826172 |
| 84 | TBK1 | 0.33585293 |
| 85 | PRKCA | 0.33353719 |
| 86 | MATK | 0.31677128 |
| 87 | TYK2 | 0.31502558 |
| 88 | BRSK1 | 0.31256093 |
| 89 | CSNK1A1L | 0.30943026 |
| 90 | PRKCD | 0.30881774 |
| 91 | BRSK2 | 0.30259434 |
| 92 | IGF1R | 0.29526690 |
| 93 | CSNK2A1 | 0.29317346 |
| 94 | JAK2 | 0.28611820 |
| 95 | PKN1 | 0.28082860 |
| 96 | CSNK2A2 | 0.27162520 |
| 97 | CDK8 | 0.26114298 |
| 98 | MAPKAPK5 | 0.25568666 |
| 99 | CSNK1A1 | 0.24989766 |
| 100 | MAPK11 | 0.24539907 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Graft-versus-host disease_Homo sapiens_hsa05332 | 4.26793663 |
| 2 | Primary immunodeficiency_Homo sapiens_hsa05340 | 4.08999837 |
| 3 | Proteasome_Homo sapiens_hsa03050 | 3.84800691 |
| 4 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.80206002 |
| 5 | Allograft rejection_Homo sapiens_hsa05330 | 3.62592857 |
| 6 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.26254813 |
| 7 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 3.12722977 |
| 8 | Antigen processing and presentation_Homo sapiens_hsa04612 | 3.10561102 |
| 9 | Asthma_Homo sapiens_hsa05310 | 2.75191280 |
| 10 | Parkinsons disease_Homo sapiens_hsa05012 | 2.70255696 |
| 11 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.35225208 |
| 12 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.25064421 |
| 13 | Ribosome_Homo sapiens_hsa03010 | 2.13782802 |
| 14 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.07675945 |
| 15 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.03340080 |
| 16 | Alzheimers disease_Homo sapiens_hsa05010 | 1.81286756 |
| 17 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.65152863 |
| 18 | Viral myocarditis_Homo sapiens_hsa05416 | 1.62726866 |
| 19 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.55025008 |
| 20 | Huntingtons disease_Homo sapiens_hsa05016 | 1.54520403 |
| 21 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.45872398 |
| 22 | Protein export_Homo sapiens_hsa03060 | 1.43492887 |
| 23 | RNA polymerase_Homo sapiens_hsa03020 | 1.37596344 |
| 24 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.32356557 |
| 25 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.30856521 |
| 26 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.17583020 |
| 27 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.11218422 |
| 28 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.06607478 |
| 29 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.05440404 |
| 30 | Salmonella infection_Homo sapiens_hsa05132 | 1.03186849 |
| 31 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.99370716 |
| 32 | * Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.98965465 |
| 33 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.97922302 |
| 34 | Peroxisome_Homo sapiens_hsa04146 | 0.95483512 |
| 35 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.94834929 |
| 36 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.90452425 |
| 37 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.88788624 |
| 38 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.87826843 |
| 39 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.85014134 |
| 40 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.83148737 |
| 41 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.82142874 |
| 42 | Phototransduction_Homo sapiens_hsa04744 | 0.81976950 |
| 43 | Measles_Homo sapiens_hsa05162 | 0.78607507 |
| 44 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.78344369 |
| 45 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.78334596 |
| 46 | Shigellosis_Homo sapiens_hsa05131 | 0.74192689 |
| 47 | Leishmaniasis_Homo sapiens_hsa05140 | 0.73101223 |
| 48 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.71103720 |
| 49 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.70183950 |
| 50 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.69362262 |
| 51 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.66314674 |
| 52 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.62257624 |
| 53 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.61856182 |
| 54 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.60176784 |
| 55 | Homologous recombination_Homo sapiens_hsa03440 | 0.58868283 |
| 56 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.57386963 |
| 57 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.57127156 |
| 58 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.56487508 |
| 59 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.55615554 |
| 60 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.54406693 |
| 61 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.52489979 |
| 62 | Retinol metabolism_Homo sapiens_hsa00830 | 0.51771013 |
| 63 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.50851167 |
| 64 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.50154411 |
| 65 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.49135808 |
| 66 | Sulfur relay system_Homo sapiens_hsa04122 | 0.47721094 |
| 67 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.47281319 |
| 68 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.46527288 |
| 69 | Pertussis_Homo sapiens_hsa05133 | 0.44307415 |
| 70 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.43680998 |
| 71 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.43007118 |
| 72 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.42549875 |
| 73 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.42045495 |
| 74 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.41405110 |
| 75 | Tuberculosis_Homo sapiens_hsa05152 | 0.41278170 |
| 76 | Olfactory transduction_Homo sapiens_hsa04740 | 0.41267812 |
| 77 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.40493736 |
| 78 | Purine metabolism_Homo sapiens_hsa00230 | 0.37214134 |
| 79 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.36046729 |
| 80 | Basal transcription factors_Homo sapiens_hsa03022 | 0.35732371 |
| 81 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.33786534 |
| 82 | RNA degradation_Homo sapiens_hsa03018 | 0.33679854 |
| 83 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.32563771 |
| 84 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.31390015 |
| 85 | DNA replication_Homo sapiens_hsa03030 | 0.30871066 |
| 86 | Legionellosis_Homo sapiens_hsa05134 | 0.30660668 |
| 87 | Base excision repair_Homo sapiens_hsa03410 | 0.29678744 |
| 88 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.27900647 |
| 89 | Phagosome_Homo sapiens_hsa04145 | 0.27466675 |
| 90 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.24626380 |
| 91 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.23347404 |
| 92 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.22271043 |
| 93 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.20647453 |
| 94 | Spliceosome_Homo sapiens_hsa03040 | 0.20254932 |
| 95 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.18092340 |
| 96 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.17046433 |
| 97 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.16931873 |
| 98 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.16356703 |
| 99 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.16198398 |
| 100 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.16126892 |

